Sophion etablerar sig i Japan

Öppnar nytt sälj och supportkontor som ska ledas av en ledande japansk elektrofysiolog.

Chr. Hansen köper underlivshälsa

Nio studer har bevisat att Urex kan minska risken för underlivsinfektioner hos kvinnor. Nu flyttas det kanadensiska bolagets verksamhet till Köpenhamn.

Hårt tryck på Läkemedelsverket

Alltför många vill ansöka om Sverige som referensland i den decentraliserade processen för att godkänna läkemedel. Idag införs nya rutiner för att hantera situationen.

Han blir Alphahelix nya VD

Bolagets tidigare teknikchef tar ett steg upp.

Elekta säljer cancerteknik till Ryssland

Två ledande cancerkliniker i Moskva och Sibirien får Rysslands mest avancerade system för strålterapi.

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Swedish Medtech söker ekonom/jurist

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recognized as good ones: in 2008, he was awarded the Eric K. Fernström Foundation's Prize for young researchers. It isn't the first award for the Associate Professor at Gothenburg University's Sahlgrenska Academy. In 2007, he received a grant award of 16 million SEK from the European Research Council for his pioneering work.